# Rule 5 — R5-M6B Medicine Evidence Audit: RE (Red Electricity)

## 1. Document control

| Field | Value |
|-------|--------|
| **Owner** | Dr. Ghanshyam Bakalwar |
| **Phase** | R5-M6B |
| **Audit sequence** | 24 of 38 |
| **Medicine code** | RE |
| **Classification** | DOCUMENTATION_ONLY_MEDICINE_AUDIT (canonical **Electricity** category — not conventional oral materia) |
| **Audit record version** | 1.0 |
| **Audit date** | 2026-08-09 |
| **Repository base (EHAS2)** | `e3ee094300285259abba8a17a182312c3bf7a38c` |
| **Framework** | [rule-05-medicine-evidence-audit-framework-R5-M6B.md](./rule-05-medicine-evidence-audit-framework-R5-M6B.md) |
| **Index** | [rule-05-medicine-evidence-audit-index-R5-M6B.md](./rule-05-medicine-evidence-audit-index-R5-M6B.md) |
| **Audit sequence authority** | Index §2 / §3 canonical order (not registry JSON array order where it differs) |
| **Verdict code** | `RE_DOCUMENTATION_AUDIT_COMPLETE_CLINICAL_AND_SAFETY_BLOCKED` |
| **Primary blocker** | `OWNER_PRIMARY_CORPUS_NOT_LOCATED` |

**Mandatory normalizer posture:** **No normalized `MED=RE` header** exists in the available 019c normalized owner corpus. **No `MED=None` Red Electricity (RE) owner master block** exists (contrast: **WE** @ `MED=None` L1381, **YE** L1426, **GE** L1467). **Do not invent** `MED=RE`, occurrence **A**, owner wrapper/body/tip line boundaries, jsonl anchor, or declared owner length. Dedicated RE owner-primary block **was not located** in the available normalized corpus.

---

## 2. Repository / base / registry identity

| Item | Value |
|------|--------|
| **Canonical repository** | `bakalwar/EH_AROGYA_SUTRA_2` |
| **Registry version** | `ehas2-medicine-registry-v2` |
| **Medicine count** | 38 |
| **C11** | Excluded (`registry.v2.manifest.json` → `excludedCodes: ["C11"]`) |
| **Registry identity (RE code in 38-set)** | **VERIFIED** — code `RE` present in v2 registry; **not** owner-source verification |
| **Owner-primary verification** | **NO** — `OWNER_PRIMARY_CORPUS_NOT_LOCATED` |
| **Category (registry mirror)** | **Electricity — Red Electricity** · **`DERIVED_UNVERIFIED`** |
| **Canonical sequence** | **P4 → RE → S-Lass** |
| **Physical corpus walk after P4 close (L1166)** | **`MED=F1` L1169** — **no physical RE block** |
| **S-Lass physical anchor** | **`MED=SLASS` L408** — **early** in normalized file vs canonical seq **25** — **OPEN** |

---

## 3. Audit scope and non-authorization banner

This record is a **documentation-only** source and governance audit for **RE**. It:

- Inventories and compares sources; records **technical governance classifications (TGC)** **as documentation**.
- Does **not** clinically validate RE, authorize potency/dosage/**electricity use**, activate evidence, connect orchestration, or approve Rule 6 medicine relationships.
- Does **not** treat registry/legacy/dev/API/mock strings as owner-verified clinical or electricity truth.
- Preserves disease/indication **source-tier inventory** with **zero** mapping or selection authority.
- **Documentation completion creates no clinical authority and no electricity authority.**

**Posture flags (final):**

| Flag | Value |
|------|--------|
| `clinicallyValidated` | `false` |
| `rule5SafetyCoverageComplete` | `false` |
| `ownerPrimaryVerified` | `false` |
| `ownerSourceStatus` | **`NOT_LOCATED`** (index) · **`OWNER_PRIMARY_CORPUS_NOT_LOCATED`** |
| `provenanceStatus` | **`INCOMPLETE_NOT_VERIFIED`** |
| `routeAuthority` | `APPLICATION_ROUTE_AUTHORITY_NONE` |
| `potencyAuthorized` | `false` |
| `dosageAuthorized` | `false` |
| `electricityAuthorized` | `false` |
| `evidenceActivated` | `false` |
| `rule6MedicineRelationshipAuthority` | `NONE` |
| `runtimeAuthorized` | `false` |
| Mapping flags (all) | **`false`** |

---

## 4. RE canonical identity (typed tracks)

| Field | Registry v2 / legacy | Owner-primary | Notes |
|-------|----------------------|---------------|--------|
| **Code** | RE | **NOT_LOCATED** | 38-set identity **VERIFIED** only |
| **Display name** | Red Electricity | **NOT_LOCATED** | **`DERIVED_UNVERIFIED`** |
| **Group** | Electricity | **NOT_LOCATED** | Category metadata — **not** electricity authorization |
| **Polarity field** | POSITIVE | **Unanchored** | Registry mirror only — **not** verified owner bands |

---

## 5. Owner corpus: no `MED=RE` — no Red Electricity master block

Reference: legacy normalized `docs/phase-s5-mm1e/_doctor_medicine_corpus.txt` (read-only pointer; not modified; outside EHAS2 tree).

| Check | Result |
|-------|--------|
| Pattern **`^MED=RE`** | **Count 0** (entire normalized corpus file) |
| **RED ELECTRICITY (RE)** owner master under **`MED=None`** | **Absent** (WE/YE/GE electricity masters present; **RE/BE** gap) |
| **Occurrence A** | **None** — **not fabricated** |
| **Owner wrapper / body / expert-tip boundaries** | **N/A** — no dedicated RE owner block |
| **JSONL line / declared owner length** | **Not identifiable** — no RE master header |
| **Transcript byte proof** | **Not available** for RE owner-primary block |

Developer/API/mock **RE** strings elsewhere in corpus (selectors, disease maps, mixture enums, universal engine summaries, hypertension RE-ban filters, polarity maps) are **rejected** as RE owner materia authority — **`QUARANTINED_NO_OWNER_MERGE`**.

Cross-medicine prose references (**F1** paralysis “RE के साथ”, **WE/GE** philosophy mentioning RE, universal potency **RE+BE** bottle rule) are **inventory only** — **not** RE owner-primary.

---

## 6. Physical / canonical boundary map

| Boundary | Value | Notes |
|----------|--------|--------|
| **Canonical predecessor** | **P4** | Index §2 order **P3→P4→RE→S-Lass** |
| **Canonical successor** | **S-Lass** | Seq **25** — **not** started or targeted |
| **Physical immediate successor after P4** | **`MED=F1` L1169** | **OPEN** vs canonical **RE** (**CF-RE-002**; aligns **CF-P4-003**) |
| **Physical RE owner block** | **None** | No normalized block to audit line-by-line |
| **S-Lass physical file placement** | **`MED=SLASS` L408** | Canonical seq **after RE** — **OPEN** (**CF-RE-003**) |
| **Prior P4 artifact** | **Unchanged** | P4→RE canonical pointer preserved; **no rewrite** |

---

## 7. Sources and provenance

| Source ID | Classification | Reference | Status |
|-----------|----------------|-----------|--------|
| **SRC-RE-OWNER** | Owner-primary | Normalized corpus | **`OWNER_PRIMARY_CORPUS_NOT_LOCATED`** — **no `MED=RE`**; **no RED ELECTRICITY `MED=None` master** |
| **SRC-RE-REG-V2** | Registry v2 | `medicines.v2.json` **RE** | **`DERIVED_UNVERIFIED`** |
| **SRC-RE-MANIFEST** | Manifest | `registry.v2.manifest.json` | Canonical **identity inventory only** |
| **SRC-RE-LEGACY-V1** | Legacy v1 | `medicines.v1.json` **RE** | **Derived-unverified mirror** |
| **SRC-RE-MM2** | MM2 parsed | — | **`NOT_LOCATED_IN_AVAILABLE_TREES`** — **no** substantive RE tier review |
| **SRC-RE-MM2C** | MM2 clinical classification | — | **`NOT_LOCATED_IN_AVAILABLE_TREES`** — **no** substantive RE tier review |
| **SRC-RE-MM3-BOOK-OCR** | MM3/BOOK/OCR | — | **`NOT_LOCATED_IN_AVAILABLE_TREES`** — **no** substantive RE tier review |
| **SRC-RE-UCKB** | UCKB standalone | — | **`NOT_LOCATED_IN_AVAILABLE_TREES`** — **no** standalone RE tier review |
| **SRC-RE-LEGACY-DUMP** | Legacy stub | Expected dump path | **`NOT_LOCATED`** — gap **OPEN** |
| **SRC-RE-DEV-API** | Dev/API/mock | Selectors, mixtures, engine steps, filters | **`QUARANTINED_NO_OWNER_MERGE`** |
| **SRC-RE-CROSS-P4** | Prior merged P4 artifact | P4→RE boundary context only | **Quarantined inventory** — **P4 artifact unchanged** |

**No derived tier may be merged into owner-primary clinical or electricity truth.**

**Unavailable-tier posture (MM2/MM2C/MM3/BOOK/OCR/UCKB):** **`NOT_LOCATED_IN_AVAILABLE_TREES — not substantively reviewed; no Rule 5 credit; no clinical/electricity authority; no owner merge`**.

---

## 8. Technical governance classification (`TECHNICAL_GOVERNANCE_CLASSIFICATION`)

**`TECHNICAL_GOVERNANCE_CLASSIFICATION_COUNT: 10`**

| ID | Token |
|----|--------|
| **TGC-RE-001** | `OWNER_PRIMARY_CORPUS_NOT_LOCATED_NO_MED_EQ_RE_NO_RED_ELECTRICITY_MASTER_BLOCK_P4_CANONICAL_PREDECESSOR_S_LASS_CANONICAL_SUCCESSOR_PHYSICAL_P4_F1_GAP` |
| **TGC-RE-002** | `RULE4_AUTHORITY_NONE_RE_OWNER_BLOCK_ABSENT_DEV_BP_ELECTRICITY_FILTERS_QUARANTINED` |
| **TGC-RE-003** | `ELECTRICITY_CATEGORY_REGISTRY_POSITIVE_STIMULANT_VS_MISSING_OWNER_MASTER_CONVENTIONAL_ORAL_MATERIA_SEPARATION` |
| **TGC-RE-004** | `POLARITY_POTENCY_DILUTION_COADMIN_RE_BE_WE_DEV_UNIVERSAL_RULES_INVENTORY_ONLY_NO_DOSAGE_OR_ELECTRICITY_AUTHORITY` |
| **TGC-RE-005** | `DISEASE_116K_MAPPING_AUTHORITY_NONE_REGISTRY_CLUSTERS_DEV_SELECTORS_REJECTED_FOR_ACTIVATION` |
| **TGC-RE-006** | `APPLICATION_ROUTE_AUTHORITY_NONE_OWNER_ROUTE_SILENT_DEV_EXTERNAL_FORMULAS_REJECTED` |
| **TGC-RE-007** | `RULE6_COMBINATION_INVENTORY_ONLY_MIXTURE_RE_STRINGS_CROSS_MED_TIPS_NO_RUNTIME_EDGE` |
| **TGC-RE-008** | `MM2_MM2C_MM3_BOOK_OCR_UCKB_NOT_LOCATED_FAIL_CLOSED_NO_MERGE_WITH_OWNER_PRIMARY` |
| **TGC-RE-009** | `IDENTITY_CONFLICT_REGISTRY_RE_CODE_VS_NORMALIZER_HEADER_ABSENT_PARALLEL_BE_NOT_LOCATED` |
| **TGC-RE-010** | `CURE_PARALYSIS_LOW_BP_STIMULANT_HYPERTENSION_BAN_KEYWORD_RUNTIME_ACTIVATION_REJECTED` |

**TGC-RE-008 note:** **MM2**, **MM2C**, **MM3/BOOK/OCR**, and **UCKB** RE tiers were **not located** in available read-only EHAS2 trees. **Fail-closed no-merge** applies to unavailable tiers only — **not** evidence that unavailable material was reviewed, characterized, or substantively quarantined.

**Index `RECORDED_0`:** documentation audit **complete**; **zero** essential owner clinical decisions; **TGC-RE-001–010** recorded **separately** (count **10**).

---

## 9. Essential owner clinical decisions

**`ESSENTIAL_OWNER_CLINICAL_DECISIONS: NONE — BLOCKED BY MISSING VERIFIED PRIMARY AND RULE 5 SAFETY EVIDENCE`**

- **Essential owner clinical decision count:** **0**
- **No `EOD-RE` table**
- Registry/dev/cross-tier derivations and unavailable tiers are **TGC/CF/ME** — **not** owner clinical approval questions.

---

## 10. Registry-derived inventory (`DERIVED_UNVERIFIED` only)

Registry v2 **RE** mirror (inventory only): Red Electricity; **POSITIVE** stimulant electricity; motor nerves, circulation, muscles; paralysis, numbness, hypotension, cold limbs, bradycardia, syncope, atonic constipation, amenorrhea, chronic dull pain; contraindication **strings** in registry text (e.g. high BP, bleeding) — **not** operational policy without verified owner primary + Rule 5 safety evidence.

**Zero** clinical selection, electricity use, route, potency, dosage, mapping, selector, or runtime authority from registry strings alone.

---

## 11. Quarantined dev/API/mock inventory (not co-primary)

Non-exhaustive inventory tier — **rejected** for activation:

- Universal engine **Red Electricity (R.E.)** stimulant summary (low BP, weakness, paralysis)
- BP selection logic (low BP → RE; high BP → BE)
- Mixture/dev formula strings (**S1 + A3 + A1 + L1 + RE — D5**, **F2 + L1 + S1 + C1 + RE**, etc.)
- **RE+BE** same-bottle prohibition in universal potency/mixture rules block — **inventory only**; **no** enforcement authority
- Hypertension **RE ban** filters in dev/engine fragments — **quarantined**
- `"Positive": "RE"` polarity map stubs — **quarantined**

---

## 12. Electricity-category posture (documentation only)

| Topic | Posture |
|--------|---------|
| **Category** | **Electricity — Red Electricity** (registry **`group_type: Electricity`**) |
| **Conventional oral materia** | **Not assumed** — electricity master lane |
| **Polarity / potency / co-admin** | Registry + dev strings **inventory only** — **no** authorization |
| **Route / application** | Owner RE block **absent** — **`APPLICATION_ROUTE_AUTHORITY_NONE`** |
| **vs BE** | Parallel **owner-primary corpus not located** for **BE** (`MED=BE` also absent) |

---

## 13. Rule 4 / Rule 5 / Rule 6 posture

| Rule | Posture |
|------|---------|
| **Rule 4** | **NONE** in located RE owner block (block absent); dev BP/electricity filters — **quarantined** |
| **Rule 5 safety** | **`SOURCE_NOT_FOUND`** for RE-specific verified safety text; unavailable tiers **zero credit**; **`rule5SafetyCoverageComplete: false`** |
| **Rule 6** | Mixture/cross-med **RE** strings — **inventory only**; **no runtime relationship edge** |

**Clinical / safety / evidence:** **NO / NO / NONE**

---

## 14. Conflict register (`CF-RE`)

| ID | Status | Summary |
|----|--------|---------|
| **CF-RE-001** | **OPEN** | No **`^MED=RE`** and no **RED ELECTRICITY (RE)** `MED=None` master in normalized corpus |
| **CF-RE-002** | **OPEN** | Canonical **P4→RE** vs physical **`MED=F1` L1169** after P4; **no RE block** in walk |
| **CF-RE-003** | **OPEN** | Canonical **RE→S-Lass** vs **`MED=SLASS` L408** early physical placement |
| **CF-RE-004** | **OPEN** | Registry **Red Electricity / POSITIVE** vs missing owner-primary mirror |
| **CF-RE-005** | **OPEN** | Dev universal engine / polarity map **RE** stimulant rules vs absent owner master |
| **CF-RE-006** | **OPEN** | Mixture/dev formula **RE** strings vs unverified Rule 6 evidence |
| **CF-RE-007** | **OPEN** | **RE+BE** same-bottle rule (corpus universal rules) vs no verified enforcement layer |
| **CF-RE-008** | **OPEN** | MM2/MM2C/MM3/BOOK/UCKB/legacy dump **`NOT_LOCATED`** for RE tier review |
| **CF-RE-009** | **OPEN** | High-stakes registry clusters (paralysis, hemiplegia, syncope) + dev hypertension **RE ban** — inventory only |
| **CF-RE-010** | **OPEN** | No jsonl line/declared length anchor for RE owner master |
| **CF-RE-011** | **OPEN** | Cross-medicine RE references (F1 paralysis+RE, WE/GE prose) vs single RE authority boundary |
| **CF-RE-012** | **CLOSED** | Dev/mock **selector / 116k RE priority / engine default RE** activation **REJECTED** (TGC-RE-005, TGC-RE-010) |
| **CF-RE-013** | **CLOSED** | Cursor-save / 116k keyword / database-save framing in **other** blocks **excluded** from RE owner merge (governance exclusion only) |

**Mandatory CF summary:** CF: 001–011 OPEN (11 entries) · 012–013 CLOSED (2 entries; governance rejections only)

---

## 15. Missing-evidence register (`ME-RE`)

| ID | Status | Summary |
|----|--------|---------|
| **ME-RE-001** | **OPEN** | Transcript bytes / jsonl anchor for RE owner master — **not located** |
| **ME-RE-002** | **OPEN** | License / publication / redistribution provenance for RE primary text |
| **ME-RE-003** | **OPEN** | Owner-primary Rule 5 safety text for RE electricity use |
| **ME-RE-004** | **OPEN** | Verified route / application (oral vs external) evidence |
| **ME-RE-005** | **OPEN** | Potency / polarity / dilution protocol ceilings |
| **ME-RE-006** | **OPEN** | Electricity-use and **RE+BE** co-administration evidence |
| **ME-RE-007** | **OPEN** | Rule 6 / mixture / cross-med relationship evidence |
| **ME-RE-008** | **OPEN** | High-stakes escalation (paralysis, BP, bleeding contraindications) vs standard care |
| **ME-RE-009** | **OPEN** | Registry / owner reconciliation for **RE** |
| **ME-RE-010** | **OPEN** | MM2/MM2C/MM3/BOOK/UCKB bibliographic location — **not located** |

Evidence gaps only — **not** EODs.

**Mandatory ME summary:** ME: 001–010 OPEN (10 entries)

---

## 16. Audit footer (mandatory)

| Item | Value |
|------|--------|
| Medicine | RE (24/38) |
| Canonical main SHA | `e3ee094300285259abba8a17a182312c3bf7a38c` |
| Verdict | `RE_DOCUMENTATION_AUDIT_COMPLETE_CLINICAL_AND_SAFETY_BLOCKED` |
| Owner-primary | **`OWNER_PRIMARY_CORPUS_NOT_LOCATED`** · **`NOT_LOCATED`** — **no `MED=RE`**; **no Red Electricity `MED=None` master** |
| `ownerPrimaryVerified` | **`false`** |
| Provenance | **`INCOMPLETE_NOT_VERIFIED`** |
| Essential owner clinical decisions | **NONE — BLOCKED…** (**count 0** · **`RECORDED_0`**) |
| TGC | **TGC-RE-001–010** · count **10** |
| Clinical / safety / evidence | **NO / NO / NONE** |
| Mapping flags | **all false** |
| Route / potency / dosage / electricity / Rule 6 | **NONE / false / false / false / NONE** |
| CF | **001–011 OPEN (11 entries) · 012–013 CLOSED (2 entries; governance rejections only)** |
| ME | **001–010 OPEN (10 entries)** |
| Next canonical medicine (sequence) | **S-Lass** — **not** started or targeted |
| Registry / runtime / deployment changed | **NO** |

**Authority tag:** DOCUMENTATION_ONLY_MEDICINE_AUDIT · **RE blocked · owner-primary corpus not located · no MED=RE · P4→F1 physical vs canonical RE OPEN · S-Lass early physical placement OPEN · MM2/MM2C/MM3/BOOK/UCKB not located · zero essential owner clinical decisions · no electricity-use authority**
